Evidence check: FOXO3 in the context of blood sugar

The query asks about FOXO3 in the context of blood sugar. The provided context does not contain any information on FOXO3 or blood sugar. FOXO3 is a transcription factor involved in insulin signaling and longevity pathways. Some studies suggest associations with glucose metabolism, but the evidence for direct, clinically actionable blood sugar effects from consumer DNA tests is weak. Most findings come from mechanistic or GWAS studies with small effect sizes. A consumer test like MyBody-X cannot reliably predict blood sugar levels or diabetes risk based on single FOXO3 variants. Blood sugar is strongly influenced by lifestyle, diet, and environment. Caveat: Do not make medical decisions based on a single gene. Evidence: unclear.